Neurological Institute Outcomes
Headache
OnabotulinumtoxinA Therapy for Headache
Outcomes Following OnabotulinumtoxinA Treatment (N = 1742)
2020
HIT-6 = Headache Impact Test, PHQ-9 = Patient Health Questionnaire, PROMIS = Patient Reported Outcome Measurement Information System
In 2020, the outcomes of 1742 headache patients who were treated with onabotulinumtoxinA were reviewed. More than 75% had improved or stable HIT-6 scores¹ and 90% or more similarly reported improved or stable PROMIS pain² and/or depression scores.³